FDA alignment on their Alzheimer's drug is HUGE news, and the chart is finally waking up. 📈 After that brutal sell-off, RSI is climbing out of the oversold ditch. The recent pop on lower volume suggests this could be the calm before the real storm. With a clear regulatory path, this looks like a coiled spring. I'm calling it a BUY. #BiotechBounce

Boom! The FDA just gave Cognition Therapeutics the green light for their Alzheimer's drug, and the market is screaming "YES!" 📈 The stock exploded on massive volume, blasting through resistance. Sure, the RSI is screaming overbought at 88, but this is pure, uncut momentum fueled by legit news. This isn't a fluke; it's a paradigm shift. I'm calling it a BUY on any slight pullback. This rocket has fuel. 🚀 #CGTX